Therapeutic Category of Drugs in Japan

[ Brite menu | Download htext | Download json | Help ]
Search

1st Level  2nd Level  3rd Level  4th Level  5th Level 

     ATC
 1  Agents affecting nervous system and sensory organs
 
 2  Agents affecting individual organs
 
 3  Agents affecting metabolism
 
 4  Agents affecting cellular function
 
 5  Crude drugs and Chinese medicine formulations
 
 6  Agents against pathologic organisms and parasites
   61  Antibiotics
   62  Chemotherapeutics
   63  Biological preparations
     631  Vaccines
     632  Toxins, toxoids
     633  Antitoxins, anti-leptospiral sera
     634  Human blood preparations
     635  Biological test preparations
     636  Mixed biological preparations
     639  Miscellaneous
       6391  Antiallergic preparations with tubercle bacilli
       6392  Schwartzman filtrate
       6393  Purified tuberculin
       6399  Others
         D10453  Bezlotoxumab (USAN/INN); Bezlotoxumab (genetical recombination) (JAN)
         D03305  Interferon alfa (NAMALWA) (JP17); Interferon alfa (BALL-1) (JAN); Interferon alfa (INN)
         D03304  Interferon beta (JAN)
         D03357  Interferon gamma-1a (genetical recombination) (JAN)
         D04554  Interferon beta-1a (USAN); Interferon beta-1a (genetical recombination) (JAN)
         D00746  Interferon beta-1b (USAN/INN); Interferon beta-1b (genetical recombination) (JAN)
         D02748  Peginterferon alfa-2b (USAN/INN); Peginterferon alfa-2b (genetical recombination) (JAN)
         D02747  Peginterferon alfa-2a (USAN/INN); Peginterferon alfa-2a (genetical recombination) (JAN)
         D09190  Anti-human thymocyte immunoglobulin, rabbit (JAN)
         D03940  Eculizumab (USAN/INN); Eculizumab (genetical recombination) (JAN)
         D11054  Ravulizumab (USAN); Ravulizumab (genetical recombination) (JAN)
         D03058  Basiliximab (USAN/INN); Basiliximab (genetical recombination) (JAN)
         D02596  Tocilizumab (USAN/INN); Tocilizumab (genetical recombination) (JAN)
         D02749  Teceleukin (USAN); Teceleukin (genetical recombination) (JP17)
         D08806  Histamine dihydrochloride and human normal immunoglobulin
         D11079  Satralizumab (USAN/INN); Satralizumab (genetical recombination) (JAN)
J06BB21
L03AB01
L03AB02
L03AB03
L03AB07
L03AB08
L03AB10
L03AB11
L04AA04
L04AA25
L04AA43
L04AC02
L04AC07
 
 
 
   64  Parasitics (systemic)
   69  Other agents against pathogenic organisms and parasites
 
 7  Agents not mainly for therapeutic purpose
 
 8  Narcotics

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: September 29, 2020
Classification code 87 in the Japan Standard Commodity Classification

» Japanese version